Skip to Content

Biolife Sciences Inc BLFE

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include Antimicrobial Copper Air Filters; Eco-Safe Surface Sanitizer; Eco-Safe Antimicrobial Treatment; Ultraviolet Sterilization; Non-contact Human Temperature Screening; and Next-Generation Vending Machines.

Contact
5285 Bradco Boulevard, Unit B
Mississauga, ON, L4W 2A6
T +1 833 919-1037
Sector Healthcare
Industry Medical Instruments & Supplies
Most Recent Earnings May 31, 2008
Fiscal Year End Nov 30, 2020
Stock Type Distressed
Employees 227